https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose (ATOM-7) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50481  1,000 U/L). The Australian Toxicology Monitoring (ATOM) study is a prospective observational study, recruiting via two poison information centers and four toxicology units. Patients following an acute APAP ingestion presenting < 24 hours post-ingestion were recruited. Initial samples were analyzed for APAP metabolites, those measured were the nontoxic glucuronide (APAP-Glu) and sulfate (APAP-Sul) conjugates and NAPQI (toxic metabolite) conjugates APAP-cysteine (APAP-Cys) and APAP-mercapturate (APAP-Mer). The primary outcome was hepatotoxicity. In this study, 200 patients were included, with a median ingested dose of 20 g, 191 received acetylcysteine at median time of 5.8 hours post-ingestion. Twenty-six patients developed hepatotoxicity, one had hepatotoxicity on arrival (excluded from analysis). Those who developed hepatotoxicity had significantly higher total CYP metabolite concentrations: (36.8 μmol/L interquartile range (IQR): 27.8-51.7 vs. 10.8 μmol/L IQR: 6.9-19.5) and these were a greater proportion of total metabolites (5.4%, IQR: 3.8-7.7) vs. 1.7%, IQR: 1.3-2.6, P < 0.001)]. Furthermore, those who developed hepatotoxicity had lower APAP-Sul concentrations (49.1 μmol/L, IQR: 24.7-72.2 vs. 78.7 μmol/L, IQR: 53.6-116.4) and lower percentage of APAP-Sul (6.3%, IQR: 4.6-10.9 vs. 13.1%, IQR, 9.1-20.8, P < 0.001)]. This study found that those who developed hepatotoxicity had higher APAP metabolites derived from CYP pathway and lower sulfation metabolite on presentation. APAP metabolites may be utilized in the future to identify patients who could benefit from increased acetylcysteine or newer adjunct or research therapies.]]> Wed 26 Jul 2023 18:22:28 AEST ]]> Utilisation of diet and microbial products as novel therapies for COPD https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36481 Wed 20 May 2020 16:22:43 AEST ]]> Algae and bacteria interaction in wastewater and their biotechnological applications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51087 Wed 06 Mar 2024 15:25:20 AEDT ]]> Dietary Assessment and Metabolomic Methodologies in Human Feeding Studies: A Scoping Review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54375 Tue 20 Feb 2024 20:24:25 AEDT ]]> Earthworm – PAHs Interactions with special reference to Gut flora https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55440 Thu 30 May 2024 15:41:44 AEST ]]> A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12336 Sat 24 Mar 2018 08:15:52 AEDT ]]> Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17945 Sat 24 Mar 2018 07:56:29 AEDT ]]> Extracellular Polymeric Substances Drive Symbiotic Interactions in Bacterial‒Microalgal Consortia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44755 Mon 24 Oct 2022 08:42:50 AEDT ]]>